Correction to: Molecular Psychiatry (2015) 20, 150–151; doi:10.1038/mp.2014.56; published online 3 June 2014
Following publication of this paper, the authors noticed an error regarding the direction of the association of clozapine response with polygenic score in the second sentence of the second paragraph in the right column. The corrected sentence appears below.
Furthermore, polygenic risk scores were higher in Cloz+ non-responders compared to Cloz+ responders (P=0.06).
Additional information
The online version of the original article can be found at 10.1038/mp.2014.56
Rights and permissions
About this article
Cite this article
Frank, J., Lang, M., Witt, S. et al. Erratum: Identification of increased genetic risk scores for schizophrenia in treatment-resistant patients. Mol Psychiatry 20, 913 (2015). https://doi.org/10.1038/mp.2015.52
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2015.52
This article is cited by
-
Ethnic Differences in Antipsychotic Response: What Genetic Variation Does and Does Not Tell Us
Current Behavioral Neuroscience Reports (2023)
-
The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal 18F-DOPA PET and voxel-based morphometry study
Molecular Psychiatry (2021)
-
Response to therapeutic sleep deprivation: a naturalistic study of clinical and genetic factors and post-treatment depressive symptom trajectory
Neuropsychopharmacology (2018)
-
Dysfunctional Striatal Systems in Treatment-Resistant Schizophrenia
Neuropsychopharmacology (2016)
